Sapheno-femoral junction pathology: Molecular mechanism of saphenous vein incompetence

Clinical and Applied Thrombosis/Hemostasis

Volumn 10, Issue 4, 2004, Pages 311-321

  Urbanek, Tomasz ^a   Skop, Barbara ^a   Ziaja, Krzysztof ^a   Wilczok, Tadeusz ^a   Wiaderkiewicz, Ryszard ^a   Pałasz, Artur ^a   Mazurek, Urszula ^a   Wielgus, Ewa ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

p21; Saphenous vein; Varicose veins; Vein valve

Indexed keywords

CYCLINE; FAS ANTIGEN; GENE PRODUCT; MESSENGER RNA; PROTEIN P21; PROTEIN P53;

ADULT; AGED; APOPTOSIS; APOPTOTIC INDEX; ARTICLE; CELL CYCLE; CONTROLLED STUDY; FAS GENE; FEMALE; FEMORAL VEIN; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; LONG SAPHENOUS VEIN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MOLECULAR BIOLOGY; NICK END LABELING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REAL TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAPHENO FEMORAL JUNCTION; SAPHENOUS VEIN; SAPHENOUS VEIN INSUFFICIENCY; TUMOR SUPPRESSOR GENE; TUNICA MEDIA; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE HYPERTROPHY; VEIN INSUFFICIENCY; VEIN WALL;

ADULT; AGED; ANTIGENS, CD95; APOPTOSIS; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; PROLIFERATING CELL NUCLEAR ANTIGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SAPHENOUS VEIN; TISSUE DISTRIBUTION; TUMOR SUPPRESSOR PROTEIN P53; VARICOSE VEINS;

EID: 6344258577     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960401000403     Document Type: Article

References (35)

1. Rose SS, Ahmed A. Some thoughts on the aethiology of varicose veins. J Cardiovasc Surg 1986;27:534.
2. Kock MM, Knapen MWM, Bonier HE, et al. Vascular remodeling in varicose vein wall. Angiology 1998;49: 871.
3. Vadenskiii AN, Zaitseva KK, Stoiko IM, et al. Electron microscopic research on the venous valves of the lower extremities in varicose veins. Arkh Patol 1990;52:21.
4. Jiang P, van Rij AM, Christie RA, et al. Non-saphenofemoral venous reflux in the groin in patients with varicose veins. Eur J Vasc Endovasc Surg 2001;21:550.
5. Porto LC, da Silveira PRM, de Caravalho JJ, et al. Connective tissue accumulation in the muscular layer in normal and varicose saphenous vein. Angiology 1995;46:243.
6. Kirsch D, Diens HP, Kuchle R, et al. Changes in the extracellular matrix of the vein wall-the cause of primary varicosis? Vasa 2000;29:173.
7. Parra J, Cambria RA, Hower CD, et al. Tissue inhibitor of metaloproteinase-1 is increased in the saphenofemoral junction of patients with varices in the leg. J Vasc Surg 1998;28:669.
8. Gandhi RH, Irizarry E, Nackman GB, et al. Analysis of the connective tissue matrix and proteolytic activity of primary varicose veins. J Vasc Surg 1993;18:814.
9. Saha P, Eichbaum Q, Silberman ED, et al. P21/CIP1 and Cdc25A: Competition between an inhibitor and an activator of cyclin-dependent kinases. Mol Cell Biol 1997;17: 4338.
10. Chen J, Akamatsu MI, Smith ML, et al. Characterization of p21(Cip1/Waf1) peptide domains required for cyclin E/cdk2 and PCNA interaction. Oncogene 1996;12:595.
11. Waga S, Hannon GJ, Beach D, et al. The p21 inhibitor of cyclin dependent kinases controls DNA replication by interaction with PCNA. Nature 1994;369:574.
12. Izawa A, Suzuki J, Takahashi W, et al. Transilast inhibits cardiac allograft vasculopathy in association with p21Waf1/Cip1 expression on neointimal cells in murine cardiac transplantation model. Arterioscler Thromb Vasc Biol 2001;21:1172.
13. Haunstetter A, Izumo S. Apoptosis: Basic mechanisms and implications for cardiovascular disease. Circ Res 1998;82: 1111.
14. Bennet MR, Macdonald K, Chan SW, et al. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence and apoptosis in human vascular muscle cells from atherosclerotic plaques. Circ Res 1998;82:704.
15. Aoki M, Morishita R, Matsushita H, et al. Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells: Potential role of p53 in regulation of vascular smooth muscle cell growth. Hypertension 1999;34:192.
16. Travers JP, Brookes CE, Evans J, et al. Assessment of wall structure and composition of varicose veins with reference to collagen elastin and smooth muscle content. Eur J Vasc Endovasc Surg 1996;11:230.
17. Leu HJ, Vogt M, Pfrunder H. Morphological alterations of non varicose and varicose veins (a morphological contribution of the discussion on pathogenesis of varicose veins). Bas Res Cardiol 1979;74:435.
18. Strucker M, Krey T, Rochlin A, et al. The histomorphologic changes at the sapheno-femoral junction of the greater saphenous vein. Vasa 2000;29:41.
19. De Simone JG. The ostial valve of the junction of the internal saphenous vein and the wall of the femoral vein. Phlebologie 1991;44:427.
20. Corcos L, De Anna D, Dini M, et al. Proximal long saphenous vein valves in primary venous insufficiency. J Mal Vasc 2000;25:27.
21. Svejcar J, Prerovsky I, Linhart J, et al. Content of collagen elastin and hexosamine in primary varicose veins. Clin Sci 1963;24:325.
22. Sher CJ. G1 phase progression: Cyclins on clue. Cell 1994; 79:551.
23. Chen J, Jackson PK, Kirschner MW, et al. Separate domains of p21 involved in the inhibition of cdk kinase and PCNA. Nature 1995;374:386.
24. Hsieh JK, Kletsas D, Clunn G, et al. P53, p21, and MDM2 involvement in the proliferation and apoptosis in an in vitro model of conditionally immortalized human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000; 20:636.
25. Miazaki M, Ohashi R, Tsuji T, et al. Transforming growth factor-beta 1 stimulates or inhibits cell growth via down-or up-regulation of p21/Waf1. Biochem Biophys Res Commun 1998;246:873.
26. Fisher SA, Langille BL, Srivastava D. Apoptosis during cardiovascular development. Circ Res 2000;10:856.
27. Akyurek LM, Johnsson C, Lange D, et al. Tolerance induction ameliorates allograft vasculopathy in rat aortic transplants: Influence of Fas-mediated apoptosis. J Clin Invest 1998;101:2880.
28. Chan SW, Hegyi L, Scott S, et al. Sensitivity to Fas mediated apoptosis is determined below receptor level in human vascular smooth muscle cells. Circ Res 2000;86: 1038.
29. Luo Y, Hurwitz J, Massague J. Cell cycle inhibition by independent cdk and PCNA binding domains in p21-CIP1. Nature 1995;375:159.
30. Hui Y, Yan-Li N, Xin-Li F, et al. Expression of p57/kip2, Rb protein and PCNA and their relationship with clinicopathology in human pancreatic cancer. World J Gastroenterol 2003;9:377.
31. Shen XB, Zhao XM, Hu JG, et al. Significance of cell apoptosis and expression of PCNA in gastric cancer. Shijie Huraen Xiaohua Zazhi 2000;8:1050.
32. Pappas PJ, Gwertzman GA, DeFouw D, et al. Retinoblastoma protein: A molecular regulator of chronic venous insufficiency. J Surg Res 1998;76:149.
33. Jacob MP, Badier-Commander C, Fontaine V, et al. Exracellular matrix remodeling in the vascular wall. Pathol Biol 2001;49:326.
34. Badier-Commander C, Couvelard A, Henin D, et al. Smooth muscle cell modulation and cytokine overproduction in varicose veins. An in situ study. J Pathol 2001;193: 398.
35. Ascher E, Jacob T, Hingorani A, et al. Expression of molecular mediators of apoptosis and their role in the pathogenesis of lower extremity varicose veins. J Vasc Surg 2001;33:1080.